APTX Insider Trading Activity and SEC Form 4 Filings
APTX insider trading summary
No open-market insider purchases or sales of Aptinyx Inc. (APTX) have been reported on SEC Form 4 in the past 12 months.
Latest APTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 13, 2022 | Joan W. Miller | Insider | Buy | $50K (17,700 @ $2.83) |
| Dec 6, 2021 | Norbert G Riedel | CEO | Buy | $223K (100,000 @ $2.23) |
| Dec 2, 2021 | Ashish Khanna | CFO and Cbo | Buy | $102K (45,000 @ $2.26) |
| Nov 12, 2021 | Robert J. Hombach | Insider | Buy | $179K (74,600 @ $2.40) |
| Nov 11, 2021 | Robert J. Hombach | Insider | Buy | $13K (5,400 @ $2.40) |
| Oct 26, 2020 | Adam Koppel | Director | Buy | $10.0M (3,333,333 @ $3.00) |
| Oct 26, 2020 | Bain Capital Life Sciences Partners, LP | 10% Owner | Buy | $10.0M (3,333,333 @ $3.00) |
| Oct 26, 2020 | Jeffrey Lawrence Schwartz | 10% Owner | Buy | $10.0M (3,333,333 @ $3.00) |
| Oct 26, 2020 | Bain Capital Life Sciences Fund, L.P. | 10% Owner | Buy | $10.0M (3,333,333 @ $3.00) |
| Oct 26, 2020 | BCIP Life Sciences Associates, LP | 10% Owner | Buy | $10.0M (3,333,333 @ $3.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.